Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
For a patient who previously underwent PBI and then developed a new primary in the same breast, would offer repeat PBI if there is a small area of overlap between the two expansions?
Related Questions
Is re-excision of residual disease ever itself an indication for PMRT?
How do you weigh upfront nodal burden when deciding to omit PMRT in a patient with cN1, ypN0 disease after neoadjuvant chemo, mastectomy and ALND?
How would you approach reirradiation in a patient with a history of whole-breast RT many years ago, now with a small intermediate-grade DCIS s/p lumpectomy with an elevated DCISionRT?
What are your top takeaways in Medical Oncology from SABCS 2024?
What dose of reirradiation would you consider for locally recurrent breast cancer after mastectomy, excised with positive margins?
Which patient subgroups do you plan to omit regional nodal irradiation for, given the publication of NSABP B-51?
Have the 10-year results from UK FAST-Forward presented at ESTRO 2025 impacted your practice with regard to patient selection?
How do you optimally set a patient up for breast radiation therapy if you don't have access to a breast board or wing board?
Is 5fx APBI and no endocrine therapy a new standard of care for women over 70 years old with low-risk breast cancer given the interim analysis of the EUROPA trial?
Does the presence of LCIS on pathology in a patient with IDC impact your decision to offer APBI?
